Scarica l'app Stockscreener
44.65
1.82%
0.80
Dopo l'orario di chiusura:
44.84
0.19
+0.43%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$43.85
Aprire:
$46.65
Volume 24 ore:
3.93M
Relative Volume:
2.00
Capitalizzazione di mercato:
$8.41B
Reddito:
$550.17M
Utile/perdita netta:
$201.35M
Rapporto P/E:
44.65
EPS:
1
Flusso di cassa netto:
$232.07M
1 W Prestazione:
-2.25%
1M Prestazione:
-10.02%
6M Prestazione:
-20.15%
1 anno Prestazione:
-14.37%
Intervallo 1D:
$44.59
$46.65
Intervallo di 1 settimana:
$43.60
$46.65
Portata 52W:
$43.60
$85.21
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Confronta DOCS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
44.65 | 8.26B | 550.17M | 201.35M | 232.07M | 1.00 |
|
VEEV
Veeva Systems Inc
|
220.10 | 36.70B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.67 | 12.56B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
95.75 | 8.27B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.96 | 6.59B | 11.99B | 24.18M | 234.31M | 0.2956 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Doximity (DOCS): Taking Stock of Valuation After Analyst Upgrades on AI Tools and Growth Outlook - Yahoo Finance
Doximity (DOCS) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Doximity Sees Surge as AI Tools and Analyst Ratings Impress - StocksToTrade
Is Doximity Now an Opportunity After Recent Share Price Slide? - Yahoo Finance
Doximity rises after Morgan Stanley upgrades to 'overweight' - TradingView — Track All Markets
Doximity (NASDAQ:DOCS) Shares Gap UpStill a Buy? - MarketBeat
Doximity Offers Attractive Entry Point, Morgan Stanley Says - marketscreener.com
Doximity upgraded at Morgan Stanley on expanding market for HCP platforms - Seeking Alpha
Doximity’s underperformance at odds with improving business, says MS - Investing.com
Morgan Stanley Upgrades Doximity to Overweight From Equalweight, Raises Price Target to $65 From $62 - marketscreener.com
Morgan Stanley upgrades Doximity stock to Overweight on conservative outlook - Investing.com Canada
Liontrust Investment Partners LLP Increases Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
AI Stocks: Will Doximity Inc stock keep outperforming rivals2025 Risk Factors & High Conviction Buy Zone Picks - moha.gov.vn
Published on: 2025-12-13 18:23:14 - moha.gov.vn
Healthcare AI Exits Pilot Phase, Enters Production Deployment - AI Magazine
Doximity (NASDAQ:DOCS) Reaches New 52-Week LowWhat's Next? - MarketBeat
Hims & Hers Expands Its Technology-Driven Personalized Virtual Care - The Globe and Mail
Federated Hermes Inc. Has $11.47 Million Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Baird Financial Group Inc. Invests $4.14 Million in Doximity, Inc. $DOCS - MarketBeat
Doximity: Inside the Multimodal Surge — How a 5% Feature Became 40% of Bookings in One Year! - Smartkarma
Barclays Initiates Coverage on Doximity (NASDAQ:DOCS) - MarketBeat
Natixis Grows Position in Doximity, Inc. $DOCS - MarketBeat
Invesco Ltd. Has $116.20 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Norges Bank Invests $6.21 Million in Doximity, Inc. $DOCS - MarketBeat
Prudential Financial Inc. Has $680,000 Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity, Inc. $DOCS Holdings Cut by First Trust Advisors LP - MarketBeat
Is Doximity’s (DOCS) AI Surge Turning Workflow Tools Into Its Core Investment Story? - Sahm
Doximity (DOCS) Gains Overweight Rating from Barclays | DOCS Sto - GuruFocus
Rep. Jonathan L. Jackson Sells Doximity, Inc. (NASDAQ:DOCS) Shares - MarketBeat
Here's Why We Think Doximity (NYSE:DOCS) Is Well Worth Watching - Yahoo Finance
Illinois Rep. Jonathan Jackson Sold Up to $80K Worth of Doximity Stock - Benzinga
Doximity: Strong Quarter Overshadowed By Policy-Driven Budget Uncertainty (NYSE:DOCS) - Seeking Alpha
Doximity stock holds steady as Wells Fargo maintains Equal Weight rating By Investing.com - Investing.com South Africa
Doximity stock holds steady as Wells Fargo maintains Equal Weight rating - Investing.com Canada
New York State Common Retirement Fund Reduces Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity: Elite Margins, AI Growth, And An Attractive Multiple (NYSE:DOCS) - Seeking Alpha
Doximity (NASDAQ:DOCS) Trading Down 10.5%Here's What Happened - MarketBeat
InvestingPro’s Fair Value model predicted Doximity’s 41% stock decline By Investing.com - Investing.com
Doximity (NASDAQ:DOCS) Hits New 52-Week LowShould You Sell? - MarketBeat
Doximity, Inc. $DOCS Shares Sold by American Century Companies Inc. - MarketBeat
Here’s How Doximity (DOCS) Regained Investors’ Trust - MSN
Doximity (DOCS) Stock Hits New 52‑Week Low After Earnings Beat – Latest News, Forecasts and Outlook as of December 5, 2025 - ts2.tech
Oversold Conditions For Doximity (DOCS) - Nasdaq
Doximity stock hits 52-week low at 45.96 USD By Investing.com - Investing.com Nigeria
Doximity stock hits 52-week low at 45.96 USD - Investing.com India
Hsbc Holdings PLC Trims Holdings in Doximity, Inc. $DOCS - MarketBeat
Will Doximity Inc. stock deliver strong dividend growthWeekly Profit Report & Proven Capital Preservation Methods - Newser
How risky is Doximity Inc. Class stock compared to peers2025 Biggest Moves & Verified Entry Point Detection - Newser
Arrowstreet Capital Limited Partnership Lowers Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Doximity (DOCS) director logs option exercise and 2,000-share sale in Form 4 - Stock Titan
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):